MODE OF ACTION OF SDZ NIM-811, A NONIMMUNOSUPPRESSIVE CYCLOSPORINE-A ANALOG WITH ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1- INTERFERENCE WITH HIV PROTEIN-CYCLOPHILIN-A INTERACTIONS
A. Billich et al., MODE OF ACTION OF SDZ NIM-811, A NONIMMUNOSUPPRESSIVE CYCLOSPORINE-A ANALOG WITH ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1- INTERFERENCE WITH HIV PROTEIN-CYCLOPHILIN-A INTERACTIONS, Journal of virology, 69(4), 1995, pp. 2451-2461
Cyclosporins, in particular the nonimmunosuppressive derivative SDZ NI
M 811, exhibit potent anti-human immunodeficiency virus type 1 (HIV-1)
activity in vitro. SDZ NIM 811 interferes at two stages of the viral
replication cycle: (i) translocation of the preintegration complex to
the nucleus and (ii) production of infectious virus particles. Immunos
uppressive activity is not correlated with anti-HIV-1 activity of cycl
osporins. However, binding to cyclophilin A, the major cellular recept
or protein of cyclosporins, is a prerequisite for HIV inhibition: all
structural changes of the cyclosporin A molecule leading to loss of af
finity to cyclophilin abolished the antiviral effect. Cyclosporin deri
vatives did not interact directly with HIV-1 proteins; cyclophilin was
the only detectable receptor protein for antivirally active cyclospor
ins. There is no evidence that inhibition of HIV occurs via a gain of
function of cyclophilin in the presence of cyclosporins: the complex o
f cyclophilin A with SDZ NIM 811 does not bind to calcineurin or to an
y other viral or cellular proteins under conditions in which calcineur
in binding to the cyclophilin A-cyclosporin A complex is easily detect
able. Thus, the loss of function caused by binding of cyclosporins to
cyclophilin seems to be sufficient for the anti-HIV effect. Cyclophili
n A was demonstrated to bind to HIV-1 p24(gag), and the formation of c
omplexes was blocked by cyclosporins with 50% inhibitory concentration
s of about 0.7 mu M. HIV-2 and simian immunodeficiency virus are only
weakly or not at all inhibited by cyclosporins. For gag-encoded protei
ns derived from HIV-1, HIV-2, or simian immunodeficiency virus particl
es, cyclophilin-binding capacity correlated with Sensitivity of the vi
ruses to inhibition by cyclosporins. Cyclophilin A also binds to HIV-1
proteins other than gag-encoded proteins, namely, p17(gag), Nef, Vif,
and gp120(env); the biological significance of these interactions is
questionable. We conclude that HIV-1 Gag-cyclophilin A interaction may
be essential in HIV-1 replication, and interference with this interac
tion may be the molecular basis for the antiviral activity of cyclospo
rins.